Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
05/2002
05/02/2002EP1200116A2 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS
05/02/2002EP1200115A2 Multi-dose erythropoietin formulations
05/02/2002EP1200108A1 Use of ginkgo extract
05/02/2002EP1200106A1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement
05/02/2002EP1200096A1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same
05/02/2002EP1200053A1 Stable hydrogenated lupulone antibacterial oral compositions
05/02/2002EP0840740B1 New inhibitors of platelet aggregation
05/02/2002CA2425974A1 Antiperspirant salts for enhanced cosmetic products
05/02/2002CA2425283A1 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/02/2002CA2358832A1 Method of reducing dentrifice compositions abrasivity by incorporation of zinc citrate
05/01/2002CN1347413A Crystalline form of omeprazole
05/01/2002CN1347327A Methods for glucagon suppression
05/01/2002CN1347324A Composition for treatment of psoriasis
05/01/2002CN1347320A Use of cholesterol-lowering agent
05/01/2002CN1347304A 口腔护理组合物 The oral care composition
04/2002
04/30/2002US6379707 Solid solution of amorphous pharmaceutically active agent, pharmaceutically acceptable hydrophobic vehicle, stabilizer, disintegrant; shelf life
04/30/2002US6379401 Alkaline agent, peroxygen salt and polymer thickeners and nonionic surfactant
04/30/2002CA2096963C A two-phase topical composition
04/30/2002CA2020247C Antibodies reactive with human carcinomas
04/25/2002WO2002032901A2 Bridged piperazine derivatives
04/25/2002WO2002032444A1 Novel medicinal herbal composition for treating liver diseases and hiv
04/25/2002US20020049291 Hydroxyl-containing polymer of given formula, such as hydrolysed maleic anhydride-vinyl acetate copolymer; abrasion resistant coatings for fertilizer; coated seeds
04/25/2002US20020049183 Phospholipids, espeically phosphatidylethanolamines, covalently bound to physiologically acceptable monomers or polymers.
04/25/2002US20020048611 Anti-microbial-adhesion fraction derived from vaccinium
04/25/2002US20020046432 Dye composition for keratin fibres, with a cationic direct dye and a substantive polymer
04/25/2002US20020046431 Composition for the oxidation dyeing of keratinous fibers comprising at least one oxidation dye and at least one cationic amphiphilic polymer, and dyeing methods
04/25/2002CA2425900A1 Novel medicinal herbal composition for treating liver diseases and hiv
04/25/2002CA2423789A1 Bridged piperazine derivatives
04/24/2002EP1198237A1 Herbal compositions for itchy or infected skin
04/24/2002EP1198222A1 Skin care composition
04/24/2002EP1198221A1 Skin care composition
04/24/2002EP1035858B1 Use of ginkgo biloba extracts for preparing a medicine
04/24/2002CN1346393A Adhesives
04/23/2002US6376657 Pharmaceutical compositions having appetite suppressant activity
04/23/2002US6376552 Treatment of gallstones
04/23/2002US6376438 Skin-compatible hand cleanser, especially a course hand cleanser
04/23/2002US6375962 React with alkylating agents such as mustard gas; may contain perfluoropolymers which are effective barrier compounds for pesticides, industrial solvents and chemical warfare agents
04/23/2002US6375937 Antiperspirant salts for enhanced cosmetic products
04/23/2002CA2069296C Combination preparation with antithrombotic action
04/23/2002CA2067395C Antimetastatically acting agents
04/18/2002WO2002030394A2 Medicinal aerosol formulations
04/18/2002WO2002030393A2 Polymeric delivery formulations of leuprolide with improved efficacy
04/18/2002US20020045617 Act preferentially on M4 receptors; side effect reduction; used to treat nervous system disorders, psychological disorders and as an analgesic; Alzheimer's disease; Cognition activators.
04/18/2002US20020045599 Crystalline adefovir dipivoxil
04/18/2002US20020044976 Microparticles
04/18/2002US20020044965 Side effect profile reduction
04/18/2002US20020044950 Recombinant toxin fragments
04/18/2002US20020044899 Controlled, super-fine grinding so particles react completely during leaching; extraction of copper from copper sulfide ores and concentrates
04/18/2002US20020043207 Oxidizing 2-((diphenylmethyl)thio)acetamide with hydrogen peroxide in mixture of mineral acid with alcohol or phase transfer catalyst, precipitating solid, and separating
04/18/2002CA2425035A1 Medicinal aerosol formulations
04/17/2002EP1196418A1 METHOD FOR PREPARING SUBSTITUTED 1,4]DIAZEPINO 6,7,1- i hi /i ]INDOL-4-ONES
04/17/2002EP1196183A2 Oregano-based therapeutic composition
04/17/2002EP1152755B1 Essential fatty acids in the prevention of cardiovascular events
04/17/2002EP1139981A4 Compositions and methods of using the same
04/17/2002EP0706395B1 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
04/17/2002EP0663830B1 Method of treating lung disease with uridine triphosphates
04/17/2002CN1345251A Methods and compositions for healing and repair of articular cartilage
04/17/2002CN1345242A Method for treatment of leukaemia
04/17/2002CN1082821C Antibody cojugates
04/17/2002CN1082820C Purified extract of harpagophytum procumbens and/or Harpagophytum zeyherii DENCE, process for its prodn. and its use
04/17/2002CN1082819C United pharmaceutical system for abrogation of viral resistance to nucleoside analogues by double-stranded RNAS
04/17/2002CN1082810C 洗涤剂组合物 Detergent composition
04/17/2002CN1082809C 肥皂组合物 Soap compositions
04/16/2002US6372776 Crystalline(−)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen maleate
04/16/2002US6372768 2-aminopyridines containing fused ring substituents
04/16/2002US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor
04/16/2002US6372746 Derivatives of acyl-piperazinyl-pyrimidines, preparation thereof and application as medicaments
04/16/2002US6372728 Formulation for treatment of osteoporosis
04/11/2002WO2002028351A2 Recombinant mucin binding proteins from steptococcus pneumoniae
04/11/2002WO2002011687A3 Epilatory compositions
04/11/2002US20020042530 Compositions and methods for their preparation from lepidium
04/11/2002US20020042517 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
04/11/2002US20020042392 Anticancer agents
04/10/2002EP1194525A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions
04/10/2002EP1194404A1 Inhibitors of aspartyl protease
04/10/2002EP1194186A2 CARDIOACTIVE COMPOSITION COMPRISING L-CARNITINE AND ITS DERIVATIVES AND i CRATAEGUS /i EXTRACTS
04/10/2002EP1194140A1 Pharmaceutical composition containing fenofibrate and preparation method
04/10/2002EP1194115A1 Topically applied idebenone-containing agent with protective and regenerative effect
04/10/2002CN1082367C Topical ophthalmic formulations contg. doxepin derivatives for treating allergic eye diseases
04/10/2002CN1082361C Stable aqueous abrasive peroxide tooth whitening dentifrice for tooth
04/09/2002US6369224 Spiroazabicyclic heterocyclic amine borane complexes; psychological, nervous system and brain disorders; anxiolytic agents, antidepressants, analgesics; alzheimer*s and parkinson*s disease; smoking cessationa
04/09/2002US6369085 Form of S-omeprazole
04/09/2002CA2229000C 1-biphenylimidazole derivatives, their preparation and their therapeutic use
04/09/2002CA2210198C Novel hair relaxer compositions and method for preparing same
04/09/2002CA2061239C Polyhydroxycyclopentane derivatives, their preparation and their therapeutic use
04/04/2002WO2001087237A3 Apparatus and process for in situ manufacture of essence from living, uncut plants
04/04/2002WO2001055178A9 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
04/04/2002WO2001039720A3 Dna polymerase inhibitors, mikanolide and dihydromikanolide
04/04/2002US20020040149 EP4 receptor selective agonists in the treatment of osteoporosis
04/04/2002US20020040139 Intranasal formulations for treating sexual disorders
04/04/2002US20020040012 A synthetic pentasaccharide which is a selective inhibitor of faxtor xa, acting via antithrombin III
04/04/2002DE10045380A1 Verfahren zur Kontrazeption und dessen Darreichungsform Method of contraception and its dosage form
04/03/2002EP1192256A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance
04/03/2002EP1192157A1 Bispidine compounds useful in the treatment of cardiac arrhythmias
04/03/2002EP1192156A1 Bispidine compounds useful in the treatment of cardiac arrhythmias
04/03/2002EP1192155A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
04/03/2002EP1192154A1 Bispidine compounds useful in the treatment of cardiac arrhythmias
04/03/2002EP1192125A2 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
04/03/2002EP1191920A2 Method for permanently shaping keratin fibres, and agents
04/03/2002EP1052973B1 Transmucosal formulations of levosimendan